A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

​ Conditions: Diabetes Mellitus, Type 1

Interventions: Drug: Baricitinib; Drug: Placebo

Sponsors: Eli Lilly and Company

Not yet recruiting Conditions: Diabetes Mellitus, Type 1
Interventions: Drug: Baricitinib; Drug: Placebo
Sponsors: Eli Lilly and Company
Not yet recruiting